论文部分内容阅读
本文选择了年龄、身高、体重和绝经后期限相仿的绝经后妇女101例。首先讯问病史;按无、轻、中和重四级,对潮热、头痛、头晕、易激动、忧郁、焦虑、失眠等14种症状进行评分。然后作体格检查;并采晨血以放射免疫法测定血清FSH浓度和进行血钙及碱性磷酸酶的测定。最后将患者随机分成三组进行治疗:第一组每天口服乙炔雌二醇5μg(简称炔雌醇组);第三组每天口服炔诺酮5 mg(简称炔诺酮组);第二组同时服用乙炔雌二醇和炔诺酮(简称联合用药组)。服药四周后再次讯问症状改善情况;按同法对上述14种症状再次
This article chooses 101 age, height, weight and postmenopausal women with similar duration. First of all, medical history was examined. Fourteen symptoms of hot flashes, headache, dizziness, agitation, melancholy, anxiety and insomnia were scored according to no, light, medium and heavy grades. And then physical examination; and morning blood collected by radioimmunoassay of serum FSH concentration and determination of serum calcium and alkaline phosphatase. Finally, the patients were randomly divided into three groups for treatment: the first group of oral administration of ethinyl estradiol 5μg (ethinylestradiol group); the third group of oral norethindrone 5 mg (abbreviation norethindrone group); the second group Taking ethinyl estradiol and norethindrone (referred to as the combination group). Medication again after four weeks to ask about the improvement of symptoms; according to the law on the above-mentioned 14 kinds of symptoms again